ÂÜÀòÂÒÂ×

Nick Nieland OLY is an accomplished equity analyst specializing in the healthcare sector, currently employed at Rokos Capital Management since April 2021. Prior experience includes roles at Citi as an equity analyst focused on pharmaceuticals, and at Novartis as a financial and strategy analyst. Nick also served as an equity analyst at Morgan Stanley for nearly a decade, concentrating on pharmaceuticals, and held a position at Javelin. In addition to a robust finance career, Nick is a three-time Olympian and a Commonwealth Gold Medallist. Academically, Nick Nieland earned a PhD in Organic Chemistry from the University of Bristol between 1991 and 1998.